TABLE 3.
Method | Serotype | |||||||
---|---|---|---|---|---|---|---|---|
HC02 | 4 | 4+5 | 3+6 | 1+4 | 2+6 | NT | NT | NT |
HC03 | 1+4 | NT | 3 | 1+4 | 6 | 1+2 | 1+3 | 1+4 |
RFLP | 4 | 1a | NDa | 1a | 1a | 4 | 3a | 4 |
ND, not done due to insufficient material.
Method | Serotype | |||||||
---|---|---|---|---|---|---|---|---|
HC02 | 4 | 4+5 | 3+6 | 1+4 | 2+6 | NT | NT | NT |
HC03 | 1+4 | NT | 3 | 1+4 | 6 | 1+2 | 1+3 | 1+4 |
RFLP | 4 | 1a | NDa | 1a | 1a | 4 | 3a | 4 |
ND, not done due to insufficient material.